marijuana stocks

Players Network (PNTV)

 
Income Statement Get Income Statement for:
View: Annual Data | Quarterly Data All numbers in thousands
Period Ending Dec 31, 2014 Sep 30, 2014 Jun 30, 2014 Mar 31, 2014
Total Revenue (132) 0   141   0  
Cost of Revenue (58) 77 191 46
Gross Profit (74) (77) (50) (46)
Operating Expenses
Research Development
Selling General and Administrative 196 1,311 246 537
Non Recurring
Others 7 7 7 6
Total Operating Expenses
Operating Income or Loss (278) (1,396) (302) (588)
Income from Continuing Operations
Total Other Income/Expenses Net (139) (245) 226 (320)
Earnings Before Interest And Taxes (416) (1,642) (77) (908)
Interest Expense 192 104 60 68
Income Before Tax (608) (1,746) (136) (976)
Income Tax Expense
Minority Interest 2 183
Net Income From Continuing Ops (249) (1,563) (136) (976)
Non-recurring Events
Discontinued Operations
Extraordinary Items
Effect Of Accounting Changes
Other Items
Net Income (606) (1,563) (136) (976)
Preferred Stock And Other Adjustments
Net Income Applicable To Common Shares (606) (1,563) (136) (976)

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Trulieve Cannabis Corp. (TCNNF) and Blue River™ Bring Premium-Grade Cannabis Extracts to Florida

Trulieve and Blue River™ Bring Premium-Grade Cannabis Extracts to Florida   Trulieve…

$AERO to Present at the 27th Annual Roth Conference

AeroGrow to Present at the 27th Annual Roth Conference BOULDER, CO–(Marketwired –…

CLS Holdings USA, Inc. (CLSH) Reviews Record Breaking and Transformational 2021 and Releases 2022 Outlook

CLS Holdings USA, Inc. Reviews Record Breaking and Transformational 2021 and Releases…

Dragonfly Therapeutics Announces AbbVie (ABBV) Opt-In of TriNKET™ Immunotherapy Drug Candidate

Dragonfly Therapeutics Announces AbbVie Opt-In of TriNKET™ Immunotherapy Drug Candidate Dragonfly Therapeutics…